Glucose Metabolism Disorders  >>  Linjeta (prandial insulin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Linjeta (prandial insulin) / Ipsen
NCT01000922: A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro

Completed
2
24
US
Regular Human Insulin, Lispro, VIAject, VIAject 50%, VIAject/Insulin Glargine, Insulin Glargine/VIAject
Biodel
Diabetes Mellitus
01/08
01/08
NCT01067118: A Randomized Control Trial Comparing Linjeta Versus Humalog in Pumps: Effect on Postprandial Blood Sugars.

Withdrawn
2
0
US
LINjeta U-100 Insulin, VIAject U-100, Humalog U-100, Lispro U-100 insulin
Stanford University, Biodel, University of Colorado, Denver
Diabetes Mellitus
01/11
06/11

Download Options